Stay updated on Biomarker-Based AML Treatment Clinical Trial
Sign up to get notified when there's something new on the Biomarker-Based AML Treatment Clinical Trial page.

Latest updates to the Biomarker-Based AML Treatment Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision history now includes a new revision v3.3.2 and removal of v3.2.0; the rest of the study record version list remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoval of the government funding lapse notice from the page; the message explaining potential delays and where to check operating status is no longer shown. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check33 days agoChange DetectedThe latest version updates the study status and oversight information as of 2024-09-16, reflecting changes to the record’s status and related governance details.SummaryDifference0.1%

- Check62 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference11%

- Check69 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

- Check83 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed as a minor UI change.SummaryDifference0.7%

Stay in the know with updates to Biomarker-Based AML Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker-Based AML Treatment Clinical Trial page.